| Medical and Health Sciences | Lifetime | 477 | DE 14 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 526 | DE 34 | 99.89 |
| Cardiology and Cardiovascular Medicine | Lifetime | 111 | DE 5 | 99.89 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 110 | DE 3 | 99.67 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 221 | DE 16 | 99.44 |
| Pulmonary and Respiratory Medicine | Lifetime | 452 | DE 20 | 99.41 |
| Complementary and Alternative Medicine | Lifetime | 855 | DE 30 | 90.08 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 31 | DE 1 | 99.67 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 193 | DE 8 | 98.79 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 495 | DE 22 | 94.54 |
| Hormonal Regulation and Hypertension | Lifetime | 14 | DE 2 | 99.82 |
| Electrolyte and hormonal disorders | Lifetime | 16 | DE 2 | 99.62 |
| Heart Failure Treatment and Management | Lifetime | 36 | DE 2 | 99.85 |
| Potassium and Related Disorders | Lifetime | 9 | DE 1 | 99.76 |
| Cardiovascular Function and Risk Factors | Lifetime | 105 | DE 3 | 99.79 |
| Blood Pressure and Hypertension Studies | Lifetime | 72 | DE 4 | 99.66 |
| Cardiac Imaging and Diagnostics | Lifetime | 137 | DE 12 | 99.74 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 436 | DE 33 | 98.85 |
| Cardiac pacing and defibrillation studies | Lifetime | 329 | DE 15 | 98.97 |
| Hemodynamic Monitoring and Therapy | Lifetime | 282 | DE 13 | 98.19 |
| Heart Rate Variability and Autonomic Control | Lifetime | 564 | DE 23 | 98.21 |
| Diabetes Treatment and Management | Lifetime | 574 | DE 35 | 97.96 |
| Acute Myocardial Infarction Research | Lifetime | 625 | DE 37 | 98.14 |
| Coronary Interventions and Diagnostics | Lifetime | 879 | DE 60 | 97.62 |
| Membrane-based Ion Separation Techniques | Lifetime | 376 | DE 9 | 96.74 |
| Lipoproteins and Cardiovascular Health | Lifetime | 953 | DE 36 | 96.50 |
| Renin-Angiotensin System Studies | Lifetime | 460 | DE 46 | 95.95 |
| Cardiac Health and Mental Health | Lifetime | 990 | DE 37 | 94.43 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 792 | DE 44 | 93.79 |
| Ion Transport and Channel Regulation | Lifetime | 779 | DE 57 | 94.20 |
| Magnesium in Health and Disease | Lifetime | 466 | DE 24 | 90.04 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 861 | DE 45 | 86.59 |
| Natural Products and Biological Research | Lifetime | 752 | DE 9 | 75.43 |
| Heart rate and cardiovascular health | Lifetime | 872 | DE 58 | 63.77 |
| Hormonal Regulation and Hypertension | 2021-2025 | 8 | DE 1 | 99.65 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 29 | DE 3 | 99.39 |
| Electrolyte and hormonal disorders | 2021-2025 | 11 | DE 1 | 97.96 |
| Heart Failure Treatment and Management | 2021-2025 | 83 | DE 4 | 99.05 |
| Diabetes Treatment and Management | 2021-2025 | 109 | DE 9 | 98.72 |
| Potassium and Related Disorders | 2021-2025 | 23 | DE 1 | 97.82 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 327 | DE 34 | 97.64 |
| Ion Transport and Channel Regulation | 2021-2025 | 207 | DE 22 | 78.22 |
| Adrenal Hormones and Disorders | 2021-2025 | 566 | DE 46 | 73.52 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 890 | DE 53 | 54.66 |
